Search

Your search keyword '"Baršić B"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Baršić B" Remove constraint Author: "Baršić B"
106 results on '"Baršić B"'

Search Results

1. Infective endocarditis in adult patients with congenital heart disease

2. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis

4. Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

5. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients

6. Managing atypical and typical herpetic central nervous system infections: results of a multinational study

12. Safety and Effectiveness of Azithromycin in the Treatment of Lower Respiratory Infections: An International, Multicenter, Non-Comparative Study

13. One-year outcome following biological or mechanical valve replacement for infective endocarditis

14. Echocardiography in detecting implantable cardioverter defibrillator lead endocarditis: case report

15. Risk factors for central nervous complications (stroke and TIA) in patients with infective endocarditis (IE)

16. RISKS FOR INFECTIVE ENDOCARDITIS (IE) IN THE ELDERLY. LESSONS FROM THE INTERNATIONAL COLLABORATION ON ENDOCARDITIS PROSPECTIVE COHORT STUDY (ICE-PCS)

17. THE EFFECT OF INiTiATION OF ANTIBIOTIC THERAPY ON THE RISK OF EMBOLIZATiON IN INFECTIVE ENDOCARDITIS: AN ANALYSIS FROM THE !CE PROSPECTIVE COHORT STUDY

20. Gynecological sepsis as an infectious problem

21. Mechanical ventilation in patients with purulent meningitis

36. Echocardiography in detecting implantable cardioverter defibrillator lead endocarditis: Case report

37. Preliminary Comparison of Molecular Antioxidant and Inflammatory Mechanisms Determined in the Peripheral Blood Granulocytes of COVID-19 Patients.

38. Ability of presepsin concentrations to predict mortality in adult patients with sepsis.

39. The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry.

40. Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

41. Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients.

42. Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital.

43. Survival after hospital discharge in patients hospitalized for acute coronavirus disease 2019: data on 2586 patients from a tertiary center registry.

44. The Impact of Severe COVID-19 on Plasma Antioxidants.

45. Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry.

46. The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry.

47. Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients.

48. DOES THE TYPE OF SURGERY IN BRAIN ABSCESS PATIENTS INFLUENCE THE OUTCOME? ANALYSIS BASED ON THE PROPENSITY SCORE METHOD.

49. Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19.

50. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Catalog

Books, media, physical & digital resources